Titlebook: Breast Cancer Metastasis and Drug Resistance; Challenges and Progr Aamir Ahmad Book 2019Latest edition Springer Nature Switzerland AG 2019

bile-acids

書(shū)目名稱Breast Cancer Metastasis and Drug Resistance影響因子(影響力)




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance影響因子(影響力)學(xué)科排名




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance被引頻次




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance被引頻次學(xué)科排名




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance年度引用




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance年度引用學(xué)科排名




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance讀者反饋




書(shū)目名稱Breast Cancer Metastasis and Drug Resistance讀者反饋學(xué)科排名

CHECK

水獺

Health and Racial Disparity in Breast Cancer,cts more than one in ten women worldwide. The chance for a female to be diagnosed with breast cancer during her lifetime has significantly increased from 1 in 11 women in 1975 to 1 in 8 women (Altekruse, SEER Cancer Statistics Review. 1975–2007. National Cancer Institute, Bethesda, 2010). This chanc

場(chǎng)所

,Breast Cancer: Current Perspectives on the?Disease Status, has shown that the past and ongoing research has an enormous implication in improving the clinical outcome in breast cancer. This has been attributed to the progress made in the realm of screening, diagnosis and therapeutic strategies engaged in breast cancer management. However, poor prognosis in

六個(gè)才偏離

,Role of Autophagy in Breast Cancer Development and Progression: Opposite Sides of the?Same Coin,s. Although autophagy is mainly accepted as a cell survival mechanism, it also modulates the process known as “type II cell death”. AKT/mTOR pathway is an upstream activator of autophagy and it is tightly regulated by the ATG (autophagy-related genes) signaling cascade. In addition, wide ranging cel

irritation

Breast Cancer Heterogeneity in Primary and Metastatic Disease, of relapse and overall survival. Traditional histopathological classification aims to categorise tumours into subgroups to inform clinical management decisions, but the diversity within these subgroups remains considerable. Application of massively parallel sequencing technologies in breast cancer

原諒

Bone Metastasis of Breast Cancer,ncer patient. Clinically, complications secondary to bone metastasis include pain, pathologic fractures, spinal cord compression, and hypercalcemia of malignancy. Because bone metastasis is extremely common in patients with metastatic breast cancer, clinical management of bone metastases is an impor

分解

Therapeutic Options for Metastatic Breast Cancer,mportant to develop therapies that go beyond those that just provide palliation of symptoms. Currently, there are several types of therapies available to help treat breast cancer including: hormone therapy, immunotherapy, and chemotherapy, with each one depending on both the location of metastases a

Osteoarthritis

Phonophobia